THE INCREASE OF CELLULAR ANTIOXIDANT ENZYMES ACTIVITY BY METABOLIC DRUG ELTACIN IN THERAPY OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE Article Kalinina E.V., Zaslavskaya R.M., Nartsissov Ya.R. Cardiology. Vol. 140. 2018. P. 402-402
ANTIOXIDANT EFFECT OF ELTACIN IN THERAPY OF PATIENTS WITH ISCHEMIC HEART DISEASE Article Kalinina E.V., Zaslavskaya R.M., Nartsissov Y.R. Cardiology. Vol. Vol 137. 2017. P. 316-316
REGULATION OF REDOX-HOMEOSTASIS BY METABOLIC DRUG ELTACIN IN THERAPY OF AGING PATIENTS WITH ISCHEMIC HEART DISEASE Article Kalinina E.V., Zaslavskaya R.M., Nartsissov Y.R. Cardiology. Vol. Vol134. 2016.
ANTIOXIDANT EFFECT OF METABOLIC DRUG ELTACIN AND ITS USE IN THERAPY OF AGING PATIENTS WITH ISCHEMIC HEART DISEASE Article Kalinina E.V., Zaslavskaya R.M., Nartsissov Y.R. Cardiology. Vol. Vol128. 2014.